Maki Namura

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A Case of Locally Advanced Breast Cancer Showing Local Enlargement during Chemotherapy, followed by Surgery and Suppression of Recurrence

A Case of Locally Advanced Breast Cancer Showing Local Enlargement during Chemotherapy, followed by Surgery and Suppression of Recurrence

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 14, 2025

A Case in Which an Immune Checkpoint Inhibitor Responded to TN Breast Cancer with a History of Leukemia and Acquired pCR

A Case in Which an Immune Checkpoint Inhibitor Responded to TN Breast Cancer with a History of Leukemia and Acquired pCR

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 14, 2025

Three Cases of HER2-Positive Breast Cancer Brain Metastases That Responded to T-DXd after Whole-Brain Radiation Therapy and Subsequent Tumor Regrowth

Three Cases of HER2-Positive Breast Cancer Brain Metastases That Responded to T-DXd after Whole-Brain Radiation Therapy and Subsequent Tumor Regrowth

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 14, 2025

A Case of Recurrent Breast Cancer That Was BRCA1 Pathogenic Variant-Positive Successfully Treated with PARP Inhibitor

A Case of Recurrent Breast Cancer That Was BRCA1 Pathogenic Variant-Positive Successfully Treated with PARP Inhibitor

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 02, 2024

Effect of Intraoperative Imprint Cytology Followed by Frozen Section on Margin Assessment in Breast-Conserving Surgery.

Effect of Intraoperative Imprint Cytology Followed by Frozen Section on Margin Assessment in Breast-Conserving Surgery.

Journal: Annals of surgical oncology

Published: March 12, 2020

The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer.

The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer.

Journal: Clinical breast cancer

Published: December 14, 2018

Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients.

Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients.

Journal: Clinical breast cancer

Published: April 11, 2018

Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.

Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.

Journal: Clinical breast cancer

Published: March 06, 2017

A patient with primary breast cancer who responded remarkably well to neoadjuvant chemotherapy with FEC100 followed by Abraxane

A patient with primary breast cancer who responded remarkably well to neoadjuvant chemotherapy with FEC100 followed by Abraxane

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 19, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026